Latest Publications

Share:

Year in Preview: Review of and Insights into Investigations by the 119th Congress

This is the fifth in our 2025 Year in Preview series examining important trends in white collar law and investigations in the coming year. We will be posting further installments in the series throughout the next several...more

False Claims Act in 2025: Looking Back and What’s Ahead

This is the fifth in our 2025 Year in Preview series examining important trends in white collar law and investigations in the coming year. We will be posting further installments in the series throughout the next several...more

BIOSECURE Act: Industry Closely Following in the Lame Duck

Congress is back in session with a loaded agenda for the lame duck period. One of the top issues the life sciences industry is tracking is the potential passage of the BIOSECURE Act. Speaker Johnson has signaled the House...more

What President-Elect Trump’s Victory Means for Healthcare in 2025

Donald Trump will be the 47th President of the U.S. Not since 1892 has a President been elected to two non-consecutive terms, and his victory has helped Republicans pick up several critical seats in Congress. Senate...more

Foley Hoag 2024 White Collar Year In Preview Series

The government had another busy year in 2023, investigating and prosecuting healthcare fraud cases on multiple fronts. Contending with the enormous healthcare crises of the now-concluded COVID-19 pandemic and the ongoing...more

Healthcare Issues to Watch Following the FY2024 Spending Deal

Six months into the fiscal year, Congress has finally passed FY2024 appropriations. It was a painstaking process, which many expected to include policy victories that both sides could celebrate. Instead, the spring work...more

Increased PFAS Reporting, Potential for Congressional Action Looms Over Industry in 2024

Congressional Activity - The challenges around addressing health concerns related to per- and polyfluoroalkyl substances (PFAS) are immense. The Environmental Protection Agency (EPA) states that PFAS are widely used, long...more

Department of State Announces Domestic Visa Renewal Pilot for Certain H-1B Visa Applicants

On December 21, 2023, the State Department announced a pilot program to resume domestic visa renewals for certain qualified H-1B nonimmigrant visa applicants. For the last 20 years, H-1B visa holders have been required to...more

OMB Releases Artificial Intelligence Memorandum to Federal Agencies

Following the landmark October 30, 2023 executive order on artificial intelligence (AI), the White House Office of Management and Budget (OMB) issued a draft memorandum to federal agency heads for the use of AI within their...more

President Biden Issues Executive Order on Use of Artificial Intelligence in Healthcare Settings

On October 30, 2023, President Biden issued an executive order (EO) to guide federal agencies on the development and use of artificial intelligence (AI). The administration views AI as holding numerous benefits but at the...more

First Rescheduling, Now SAFE: Cannabis Reform Marches Forward

Fresh on the heels of intense optimism over the Department of Health and Human Services’ recommendation that cannabis be rescheduled, another key federal reform is in motion. On September 27, 2023, the Senate Committee will...more

CMS Proposes Updates to Medicare Dental Coverage Pathway

On July 13, 2023, the Centers for Medicare and Medicaid Services (CMS) released the CY2024 Physician Fee Schedule (PFS) proposed rule. This rule addresses changes in Medicare payment policies for physician services. Over the...more

Big Four Health Committee Leaders Release Request for Information on Regulation of Cannabidiol

On July 27, 2023, House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Ranking Member Frank Pallone, Jr., (D-NJ), along with Senate Health, Education, Labor, and Pensions (HELP) Committee Chair Bernie...more

Bills Reintroduced in Congress After FDA Signals Potential New Regulatory Pathway for Cannabidiol Products

On the heels of a January 2023 statement released by the FDA expressing the need for a new regulatory pathway for cannabidiol products, two CBD-related bills were reintroduced in the House of Representatives on March 17,...more

Review of COVID-19 Testing Guidance for Travelers to the U.S.

As of December 6, 2021, all air passengers 2 years or older (regardless of vaccination or antibody status) with a flight departing to the United States from a foreign country are required to show a negative COVID-19 viral...more

House Approves COVID-19 Reconciliation Package, Measure Moves to Senate

On February 27, 2021, the House of Representatives approved the H.R. 1319, the American Rescue Plan Act of 2021. This package comprises the $1.9 trillion proposal from the White House and Congressional Democrats who intend to...more

Department of Health and Human Services Issues Request for Information on COVID-19 Best Practices

On November 23, 2020, the Department of Health and Human Services (HHS) published a Request for Information (RFI) seeking insights from health systems and providers on innovative approaches and best practices implemented in...more

What Elementary and Secondary Schools with IDEA Students Need to Know about the CARES Act

On March 27, 2020, Congress passed the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), the third and by far the largest stimulus package passed by Congress to respond to the COVID-19 outbreak. As discussed...more

19 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide